No article text was recorded for this version.
peptide metabolic instability
Version 2 of 271 papers83 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Zytokintherapie bei malignen Hauterkrankungen und insbesondere beim malignen Melanom
- Blog: Target sequence-conditioned design of peptide binders using masked language modeling
- Blog: A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo
- Blog: Computational Design of Pore-Forming Peptides with Potent Antimicrobial and Anticancer Activities
- Blog: FK-16 Derived from the Anticancer Peptide LL-37 Induces Caspase-Independent Apoptosis and Autophagic Cell Death in Colon Cancer Cells
- Blog: Inhibition of METTL14 overcomes CDK4/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ERα-positive breast cancer
- Blog: Antiplatelet Activity, P2Y1 and P2Y12 Inhibition, and Metabolism in Plasma of Stereoisomers of Diadenosine 5′,5′″-P1,P4-dithio-P2,P3-chloromethylenetetraphosphate
- Blog: Natural and redesigned wasp venom peptides with selective antitumoral activity
- Blog: Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution
- Blog: Synthetic angiotensin II peptide derivatives confer protection against cerebral and severe non-cerebral malaria in murine models
- Blog: Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
- Blog: Structure-function-guided exploration of the antimicrobial peptide polybia-CP identifies activity determinants and generates synthetic therapeutic candidates
- Blog: Intramyocardial Delivery of Basic Fibroblast Growth Factor-Impregnated Gelatin Hydrogel Microspheres Enhances Collateral Circulation to Infarcted Canine Myocardium.
- Blog: Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts.
- Blog: Hypothalamic kisspeptin alleviates myasthenia gravis by regulating Th1/Th17/Treg balance through Inhibition of NF-κB signaling pathway
- Blog: Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention
- Blog: Broad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
- Blog: Secreted recombinant human IL-24 protein inhibits the proliferation of esophageal squamous cell carcinoma Eca-109 cells in vitro and in vivo
- Blog: Exploring and expanding the chemical multiverse of peptides
- Blog: Deep learning reveals antibiotics in the archaeal proteome
- Blog: Disruption of <i>YPS1</i> and <i>PEP4</i> genes reduces proteolytic degradation of secreted HSA/PTH in <i>Pichia pastoris</i> GS115
- Blog: Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction
- Blog: Tectochrysin alleviates high-glucose-induced retinal pigment epithelial cell injury through Nrf2/HO-1 activation
- Blog: Enzymatische Hydroxylierung von Ruthenocen und Osmocen durch Leber-Mikrosomen / Enzymatic Hydroxylation of Ruthenocen and Osmocene
- Blog: Application of a new 68Ga-labeled cNGR dimer peptide to microPET imaging of ovarian cancer
- Blog: Optimization of anti-cobratoxins for treatment of neurotoxic envenomings
- Blog: Structural Characterization of Mycobacterium abscessus Phosphopantetheine Adenylyl Transferase Ligand Interactions: Implications for Fragment-Based Drug Design
- Blog: StraPep: a structure database of bioactive peptides
- Blog: Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools
- Blog: Suppression of AKT Anti-Apoptotic Signaling by a Novel Drug Candidate Results in Growth Arrest and Apoptosis of Hepatocellular Carcinoma Cells
- Blog: Ferroptosis in central nervous system injuries: molecular mechanisms, diagnostic approaches, and therapeutic strategies
- Blog: Design, synthesis, and biological evaluation of Osimertinib–Cy7 (OSA-Cy7) conjugate as potential theranostic agent targeting activating EGFR mutations
- Blog: Ribosomal translation of fluorinated non-canonical amino acids for <i>de novo</i> biologically active fluorinated macrocyclic peptides
- Blog: Generation of new inhibitors of selected cytochrome P450 subtypes– In silico study
- Blog: GSH Activated Biotin-tagged Near-Infrared Probe for Efficient Cancer Imaging
- Blog: Designing Anti-Zika Virus Peptides Derived from Predicted Human-Zika Virus Protein-Protein Interactions
- Blog: Organometallic gold(I) and gold(III) complexes for lung cancer treatment
- Blog: Mapping the S1 and S1’ subsites of cysteine proteases with new dipeptidyl nitrile inhibitors as trypanocidal agents
- Blog: IFN-γ/Doxorubicin Complex Nanoparticles for Enhancing Therapy in the Context of Human Ovarian Carcinoma
- Blog: Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas
- Blog: Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer´s Disease
- Blog: Targeting protein homeostasis with small molecules as a strategy for the development of pan-coronavirus antiviral therapies
- Blog: A practical photocatalytic strategy for radical (deuterio)difluoromethylation using imidazolium reagents
- Blog: A novel PI3K inhibitor PIK-C98 displays potent preclinical activity against multiple myeloma
- Blog: Mechanism of Action of Thalassospiramides, A New Class of Calpain Inhibitors
- Blog: Atom-level backbone engineering preserves peptide function while enhancing stability
- Blog: Synthesis and characterization of 5-(2-fluoro-4-[ <sup>11</sup> C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2 <i>H</i> -pyrano[2,3- <i>b</i> ]pyridine-7-carboxamide as a PET imaging ligand for metabotropic glutamate receptor 2
- Blog: Phase I Clinical Study of Edaravone in Healthy Chinese Volunteers
- Blog: GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
- Blog: Insights from structure-activity relationships and the binding mode of peptidic α-ketoamide inhibitors of the malaria drug target subtilisin-like SUB1
- Blog: Towards Improved Peptidic α‐Ketoamide Inhibitors of the Plasmodial Subtilisin‐Like SUB1: Exploration of <i>N</i>‐Terminal Extensions and Cyclic Constraints
- Blog: Deep-learning-enabled antibiotic discovery through molecular de-extinction
- Blog: New linear antiplasmodial peptides related to angiotensin II
- Blog: In vitro biomimetic HPLC and in vivo characterisation of GM6, an endogenous regulator peptide drug candidate for amyotrophic lateral sclerosis
- Blog: Cross-Chirality Generalization by Axial Vectors for Hetero-Chiral Protein-Peptide Interaction Design
- Blog: A Multi-Property Optimizing Generative Adversarial Network for de novo Antimicrobial Peptide Design
- Blog: TDO Target Inhibitor Research Progress Review
- Blog: Development of Highly Selective Epoxyketone-based Plasmodium Proteasome Inhibitors with Negligible Cytotoxicity
- Blog: Discovery and pharmacophoric characterization of chemokine network inhibitors using phage-display, saturation mutagenesis and computational modelling
- Blog: Aptamer-based applications for cardiovascular disease
Showing 60 of 71 papers.
History & citation
Current · Permanent link
- gastrointestinal drug degradation split from this direction (53% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_peptide_metabolic_instability_f83a6b6e,
title = {peptide metabolic instability},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/peptide-metabolic-instability/rdr_f83a6b6e3c8d4382b9ca581f8f6caa56},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_peptide_metabolic_instability_f83a6b6e_v2,
title = {peptide metabolic instability},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/peptide-metabolic-instability/rdr_f83a6b6e3c8d4382b9ca581f8f6caa56/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}